OROX BioSciences
Mehran F. Moghaddam is the CEO of OROX BioSciences, Inc., where Mehran focuses on the discovery and development of small-molecule therapeutics for patients with fibrotic and oncological ailments. With a background in pharmacokinetics and drug metabolism, Mehran has held various leadership roles at Celgene Corporation and Pfizer Inc. Mehran also has postdoctoral training in lipid-mediated inflammatory diseases. Additionally, Mehran holds a Ph.D. in Medicinal Chemistry from Oregon State University and an Executive MBA from the University of Southern California.
OROX BioSciences
OROX BioSciences harnesses the beneficial effects of inhibiting sEH selectively or in concert with secondary targets to gain efficacy and bring about a resolution to disease states such as fibrosis.